Records and reports
This section refers to the section 4.9 of the INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE ICH E6(R2), including Addenda items. It provides an overview of the requirements to the trial records management and maintenance, as well as storage, and audit trail.
4.9 Records and Reports
ADDENDUM
4.9.0 The investigator/institution should maintain adequate and accurate source documents and trial records that include all pertinent observations on each of the site’s trial subjects. Source data should be attributable, legible, contemporaneous, original, accurate, and complete. Changes to source data should be traceable, should not obscure the original entry, and should be explained if necessary (e.g., via an audit trail).
4.9.1 The investigator should ensure the accuracy, completeness, legibility, and timeliness of the data reported to the sponsor in the CRFs and in all required reports.
4.9.2 Data reported on the CRF, that are derived from source documents, should be consistent with the source documents or the discrepancies should be explained.
4.9.3 Any change or correction to a CRF should be dated, initialed, and explained (if necessary) and should not obscure the original entry (i.e., an audit trail should be maintained); this applies to both written and electronic changes or corrections (see 5.18.4 (n)). Sponsors should provide guidance to investigators and/or the investigators' designated representatives on making such corrections. Sponsors should have written procedures to assure that changes or corrections in CRFs made by sponsor's designated representatives are documented, are necessary, and are endorsed by the investigator. The investigator should retain records of the changes and corrections.
4.9.4 The investigator/institution should maintain the trial documents as specified in Essential Documents for the Conduct of a Clinical Trial (see 8.) and as required by the applicable regulatory requirement(s). The investigator/institution should take measures to prevent accidental or premature destruction of these documents.
4.9.5 Essential documents should be retained until at least 2-years after the last approval of a marketing application in an ICH region and until there are no pending or contemplated marketing applications in an ICH region or at least 2-years have elapsed since the formal discontinuation of clinical development of the investigational product. These documents should be retained for a longer period however if required by the applicable regulatory requirements or by an agreement with the sponsor. It is the responsibility of the sponsor to inform the investigator/institution as to when these documents no longer need to be retained (see 5.5.12).
4.9.6 The financial aspects of the trial should be documented in an agreement between the sponsor and the investigator/institution.
4.9.7 Upon request of the monitor, auditor, IRB/IEC, or regulatory authority, the investigator/institution should make available for direct access all requested trial-related records.
Clinical Research News
即将进行的临床试验
-
The Collagen Co. - GLP-1 UsersCitruslabs尚未招聘肥胖 | 身体构成 | 体重管理 | 皮肤健康 | Nutritional Adequacy | Hunger and Satiety | GLP-1 Receptor Agonist Use美国
-
Azienda Sanitaria Universitaria Integrata del Trentino招聘中Assess the Actual Temperature Drop of Medical Gases From the Distal End of the Heated Ventilator Circuit to the Tracheal Carina意大利
-
Xiangya Hospital of Central South University招聘中
-
University of Guelph尚未招聘This Study Explores the Relationships Between Almond Particle Size, Chewing, Gastric Emptying, and Postprandial Metabolism加拿大
-
World Society of Emergency Surgery尚未招聘败血症 | 腹腔内感染 | 肠梗阻 | 急腹症 | 急性肠系膜缺血 | 消化道穿孔 | Non-Traumatic Emergency General Surgery Conditions | Acute Gastrointestinal Hemorrhage
-
Samsung Medical CenterDaewoong Pharmaceutical Co. LTD.招聘中
-
Cairo University尚未招聘
-
Imperial College LondonCardiff University; University of Nottingham; University of Amsterdam; Newcastle University; National... 和其他合作者招聘中健康 | 支气管扩张症 | 儿科和成人患者 | 囊性纤维化 (CF) | 原发性纤毛运动障碍 (PCD) | 慢性化脓性肺病英国
-
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.尚未招聘
-
Fondazione G.B. Bietti, IRCCS尚未招聘
-
Mersin University尚未招聘
Clinical Research Jobs
-
United Kingdom - Harrogate
-
United States - Cambridge
-
Poland - Warsaw
-
Serbia - Belgrade
-
India - Karnataka - Bengaluru
-
United States - Wilmington
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China